About thymosin alpha
Immune response modifier
Used for
- Adjunct treatment for chronic hepatitis B in some countries.
- Immune support in certain cancers or infections where locally approved.
Usual adult dose
Often 1.6 mg injected under the skin twice weekly for six months; regimens vary by condition and country.
Common side effects
- Injection-site redness or discomfort
- Fever or fatigue
- Muscle or joint aches
- Nausea
Important warnings
- Approved uses and evidence vary widely between countries.
- Use only under specialist supervision; it is not a substitute for standard treatment.
- Avoid with organ transplants or immunosuppressive medicines unless a specialist approves.
Pregnancy
Safety is not established; use during pregnancy is generally avoided unless clearly necessary.
Breastfeeding
Safety is not established; breastfeeding use requires assessment by a clinician.
Interactions
- May counteract medicines that suppress immune activity, including transplant drugs.
- Potential interactions with interferon or other immune-modifying treatments are uncertain.
AI-generated from general medical knowledge, not from this product's official leaflet. It may be incomplete or out of date. Not medical advice — ask a pharmacist or doctor before making any decision.